How Diagnostic Sample Logistics Works

    Topic
    Diagnostic Logistics
    Published
    Reading time
    7 min read

    By Phlebify Operations Team · Last updated

    Laboratory staff reviewing incoming diagnostic samples at a pathology lab workstation

    It is easier to fix a workflow you can see. This article follows a single home collection request from the moment a laboratory raises it to the moment the specimen is accessioned, and names the decision made at each handoff.

    The example is a routine morning fasting profile in an Indian metro — the highest-volume, most delay-sensitive case in home collection.

    Stage 1 — Request intake

    A request enters the system carrying, at minimum:

    1. Patient name, contact number and a complete address including tower, flat and landmark
    2. Test requirement or requisition reference
    3. Fasting requirement and any pre-collection instruction
    4. Preferred collection window
    5. Referring lab, clinic or hospital identity for handover routing

    Incomplete addresses are the most common defect at this stage, and the most expensive later. A missing tower number does not cause a problem at 9 pm when the order is booked; it causes a fifteen-minute search at 6:45 am the next morning, which then delays every subsequent visit on that collector's route.

    Stage 2 — Serviceability and slot confirmation

    Before a window is promised, two questions need answering: can this address be reached, and can it be reached within the requested window given the collectors likely to be available then. Answering only the first question is how labs end up apologising to patients.

    Phlebify confirms serviceability per request rather than publishing broad locality lists, because a pin code covering both an arterial road and an interior colony does not have one honest answer.

    Stage 3 — Assignment and dispatch

    Assignment matches the request to a specific verified phlebotomist. Done manually, this is a memory-and-phone exercise: the coordinator recalls who works that area, calls two or three collectors, and takes the first yes. It works at ten collections a day and collapses at a hundred.

    Done systematically, assignment weighs collector availability, current location, the travel effort to the patient address, the existing shape of that collector's route and the constraints of the test. That is the job AI dispatch performs, using distance intelligence as its travel model.

    Stage 4 — The collection visit

    At the patient location, the collector performs a tightly sequenced set of steps. Each one is a potential pre-analytical failure point:

    • Confirm patient identity against the requisition before anything else
    • Confirm fasting status and pre-collection conditions
    • Select the correct tubes and draw order for the requested panel
    • Perform the draw to protocol, with correct mixing for additive tubes
    • Label tubes at the point of collection, in the patient's presence
    • Record the collection event and time digitally against the request
    • Give the patient a clear statement of what happens next

    Labelling is the step most worth protecting. A tube labelled later, at the car or the hub, is a tube whose identity depends on someone's memory.

    Stage 5 — Custody and packaging

    Once drawn, the specimen must have a named holder at every moment until the laboratory accepts it. Packaging follows the sample type: secondary containment for leak protection, absorbent material, and temperature control appropriate to the assay.

    The operational metric that matters here is idle time — how long a collected sample sits with a collector before it starts moving toward the lab. It is almost always the largest single block of avoidable delay in home collection, and almost never measured. Cold chain handling covers the temperature side in detail.

    Stage 6 — Sample movement to the laboratory

    Movement is either direct — collector to laboratory — or consolidated, where multiple collections meet at an agreed handover point before travelling together. Direct movement minimises time per sample; consolidation minimises cost per sample. Most operations run a mix, decided by volume density and test urgency.

    The practical rule is that urgency should drive the routing decision, not habit. A stability-sensitive specimen should not wait for a batch to fill. Diagnostic sample pickup and delivery works through the pickup models.

    Stage 7 — Handover and accessioning

    Handover is a transfer of accountability, not just of tubes. The receiving laboratory verifies the specimens against the requisition, records receipt time and condition, notes any rejection, and enters the sample into its LIMS.

    From the logistics side, the request closes when the lab has accepted the specimen. From the lab's side, this is where analytical turnaround starts. Because the two clocks meet at exactly this point, it is the single most useful event in the whole workflow to timestamp accurately.

    Who owns what

    Delay usually lives in the gaps between owners. Making ownership explicit removes most of it.

    StageOwnerRecorded outcome
    Request intakeLab / clinic / booking channelComplete, validated order
    AssignmentDispatch layerNamed collector, committed window
    CollectionPhlebotomistCollection event, time, labelled tubes
    Custody and movementPhlebotomist / runnerCustody trail, movement start time
    HandoverCollector and laboratory jointlyReceipt time, specimen condition
    ExceptionsOperations deskReason code and resolution

    Running this without building it yourself

    Most laboratories do not want to become logistics companies. They want collections to happen reliably and samples to arrive in a usable state, with visibility in between.

    That is what Phlebify provides: home sample collection and diagnostic sample pickup run as a managed workflow, with status visible to your coordination team throughout.

    Frequently asked questions

    How long should a home collection sample take to reach the laboratory?

    It depends on the assay's stability requirements rather than a single universal target. The operational goal is to minimise idle time after collection and to route stability-sensitive specimens ahead of routine batches.

    Who is accountable if a sample is rejected at accessioning?

    Accountability should be traceable to a stage, which is why collection, custody and handover events are recorded separately. A rejection due to haemolysis, insufficient volume or labelling mismatch points to different stages and different corrective actions.

    Does consolidating collections at a handover point add risk?

    It adds elapsed time, which is a risk for stability-sensitive tests, and it adds one more custody transfer. It also lowers cost per sample. The decision should be made per test category, not applied uniformly.

    Related reading

    Browse every article in the Phlebify diagnostic operations blog.